MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$360M
AUM Growth
-$12.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$13.2M
2
+$11.6M
3
+$7.25M
4
GERN icon
Geron
GERN
+$3.54M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$3.22M

Top Sells

1
+$9.43M
2
+$4.13M
3
+$3.73M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$3.67M
5
CYTK icon
Cytokinetics
CYTK
+$1.18M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$3.17M 0.88%
664,980
+370,000
27
$3M 0.83%
2,377,031
28
$2.85M 0.79%
146,041
29
$2.66M 0.74%
334,384
30
$2.53M 0.7%
20,000
31
$2.37M 0.66%
+592,435
32
$2.08M 0.58%
660,892
33
$1.63M 0.45%
193,326
34
$1.1M 0.31%
135,573
35
$1.01M 0.28%
412,363
36
$596K 0.17%
53,993
37
$590K 0.16%
239,888
38
– –
-151,750
39
– –
-99,834
40
– –
-138,000
41
– –
-351,350
1
2